Cartalax (AED Peptide, Ala-Glu-Asp) is a short 3-amino-acid bioregulator peptide developed under Prof. Vladimir Khavinson's cytomedine bioregulator program, specifically targeting cartilage and joint tissue. As a synthetic analog of the natural cartilage bioregulator, AED regulates gene expression in chondrocytes via epigenetic mechanisms (DNA methylation/histone modification) rather than receptor signaling. It is the most specific peptide for articular cartilage regeneration research, age-related cartilage degeneration and osteoarthritis models, chondrocyte proliferation and extracellular matrix synthesis, and musculoskeletal bioregulator stack studies.
Cartalax restores cartilage via targeted bioregulation. CARTALAX (AED) – Cartilage Tissue: Molecular Formula Ala-Glu-Asp (AED), MW 390.35 Da, Synthetic Short Peptide – Dipeptide-Like Bioregulator, Structure: Alanine-Glutamic Acid-Aspartic Acid Tripeptide. MECHANISM OF ACTION: 1. Cartalax binds to specific DNA regions in chondrocyte nuclei → 2. Epigenetic Regulation → upregulates chondrogenic genes: ↑COL2A1 Type II Collagen synthesis, ↑ACAN Aggrecan & Proteoglycans (GAGs), ↑SOX9 chondrocyte differentiation factor, ↓MMPs matrix metalloproteinases (degradation) → 3. Cartilage Regeneration → ↑Chondrocyte Proliferation & Differentiation → ↑Extracellular Matrix ECM Formation → Restored Articular Cartilage Structure & Elasticity. RESEARCH APPLICATIONS: Joint Health & Cartilage Regeneration – supports cartilage tissue repair models, Anti-Aging Musculoskeletal – age-related cartilage degeneration, Chondrocyte Function – cellular proliferation & ECM synthesis, Musculoskeletal Bioregulator Stacks – combines with Pinealon (brain), Vesugen (vessels), Crystagen (immune). Cartalax is part of Khavinson's peptide bioregulator library, unique for tissue-specific epigenetic regulation.
Our Cartalax lineup is supplied as high-purity lyophilized powder (>98% HPLC) with COA. For cartilage bioregulator research, Cartalax 10mg (AED – standard and most requested) is available, typically dosed in 10-20 day cycles in bioregulator protocols. Cartalax belongs to Repair & Anti-Aging Peptides category, Bioregulator sub-group, alongside Epithalax (Epithalon), Pinealon (EAK), Vesugen (KED), Crystagen (AEDG). Commonly stacked with BPC-157 5mg + TB-500 10mg Blend for comprehensive joint repair (BPC/TB for tendon/ligament + Cartalax for cartilage matrix). Stable 24 months at -20°C. For Research Use Only, not for human consumption.